| 000 | 01826 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517020735.0 | ||
| 264 | 0 | _c20150622 | |
| 008 | 201506s 0 0 eng d | ||
| 022 | _a1879-3169 | ||
| 024 | 7 |
_a10.1016/j.toxlet.2015.02.018 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhang, Pu | |
| 245 | 0 | 0 |
_aMicroRNA-33b, upregulated by EF24, a curcumin analog, suppresses the epithelial-to-mesenchymal transition (EMT) and migratory potential of melanoma cells by targeting HMGA2. _h[electronic resource] |
| 260 |
_bToxicology letters _cMay 2015 |
||
| 300 |
_a151-61 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aBenzylidene Compounds _xpharmacology |
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Movement _xdrug effects |
| 650 | 0 | 4 |
_aCurcumin _xanalogs & derivatives |
| 650 | 0 | 4 |
_aEpithelial-Mesenchymal Transition _xdrug effects |
| 650 | 0 | 4 | _aFluorescent Antibody Technique |
| 650 | 0 | 4 |
_aHMGA2 Protein _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMelanoma _xdrug therapy |
| 650 | 0 | 4 |
_aMicroRNAs _xdrug effects |
| 650 | 0 | 4 |
_aPiperidones _xpharmacology |
| 650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
| 650 | 0 | 4 |
_aUp-Regulation _xdrug effects |
| 700 | 1 | _aBai, Huiyuan | |
| 700 | 1 | _aLiu, Gentao | |
| 700 | 1 | _aWang, Heyong | |
| 700 | 1 | _aChen, Feng | |
| 700 | 1 | _aZhang, Baoshun | |
| 700 | 1 | _aZeng, Panying | |
| 700 | 1 | _aWu, Chengxiang | |
| 700 | 1 | _aPeng, Cong | |
| 700 | 1 | _aHuang, Changjin | |
| 700 | 1 | _aSong, Yang | |
| 700 | 1 | _aSong, Erqun | |
| 773 | 0 |
_tToxicology letters _gvol. 234 _gno. 3 _gp. 151-61 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.toxlet.2015.02.018 _zAvailable from publisher's website |
| 999 |
_c24663446 _d24663446 |
||